Furthermore, apoptosis in response to anticancer therapy and immune attack is attenuated under the influence of HIF-1α, limiting the efficacy of chemotherapeutics, molecularly targeted agents, and immunotherapy in gastric cancer (Pei et al., 2021; Ucaryilmaz Metin and Ozcan, 2022). Here, HIF1A is linked to gastric cancer.